Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma. Oh DH, Ma X, Hogg SJ, He J, et al. Proc Natl Acad Sci U S A 2023;120:e2306414120.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Oh DH, Ma X, Hogg SJ, He J, et al. Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma. Proc Natl Acad Sci U S A 2023;120:e2306414120.
PMID: 37643213